It also gives Cronos wider access to U.S. investors that chose not to buy into the company through its ticker on the over-the-counter market, which is how most large Canadian cannabis companies try to reach American investors. That’s because most U.S. discount brokers don’t offer clients the ability to … Read More
The post Cronos cracks the Nasdaq, a first for Canadian cannabis appeared first on Dagga Magazine.